Diksha Gupta leads business development at Kemwell Biopharma, a global biologics CDMO, driving strategic partnerships and enabling clients to scale complex antibody and protein programs. With 18+ years in biotechnology and biopharmaceuticals, she brings hands-on experience in end-to-end biologics development (recombinant proteins, biosimilars, ADCs, multispecifics) from Pfizer and Bristol Myers Squibb, alongside global product management and commercialization expertise for $600M+ portfolios at Thermo Fisher Scientific, Danaher, and Bio-Techne. Diksha is here to explore partnerships and collaborations with innovators seeking biologics development and manufacturing solutions.